Brought to you by 
Public shell, Acuity, Froptix merge, form new ophthalmic co.
02 Apr 2007
Executive Summary
Private ophthalmic firms Acuity Pharmaceuticals and Froptix are merging with eXegenics (formerly developed pharmaceuticals for cancer and infections, but now has no business activities; trades on the OTC Bulletin Board) to create the new eye care company Opko Corp.
Deal Industry
- Pharmaceuticals
-
Pharmaceuticals
-
Drug Delivery
- Macromolecule
-
Drug Delivery
-
Biotechnology
- Antisense, Oligonucleotides
- Large Molecule
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
- Reverse Acquisition
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Public shell, Acuity, Froptix merge, form new ophthalmic co.
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice